Skip to main content

Table 1 Patient background

From: Time course of serum cytokine level changes within 72 h after onset in children with acute encephalopathy and febrile seizures

Case

1

2

3

4

5

6

7

Sex

Female

Female

Male

Male

Female

Male

Male

Age (years)

3

5

9

1

3

1

8

Diagnosis

HSES

HSES

HSES

AESD

AESD

FS

FS

PCPC score before onset

3

1

1

3

1

3

1

Neurological history

Intellectual disability

None

None

Intellectual disability

None

Intellectual disability Hydrocephalus

None

Duration of fever before neurological symptom onset

0 h

1 day

1 day

1 day

0 h

1 h

1 day

Causative virus

Not detected

Influenza A

Not detected

Not detected

Not detected

Not detected

Influenza A

Initial neurological symptom

Convulsions

Convulsions

Convulsions

Convulsions

Convulsions

Convulsions

Impaired consciousness

Duration of seizures at onset (min)

950

211

40

333

99

181

Max. 360

(NCSE)

Treatment

High-dose steroid treatment, start time

+

17 h

+

7 h

+

15 h

+

5 h

Targeted temperature management, start time

+

17 h

+

6 h

+

15 h

+

6 h

+

12 h

+

5 h

+

12 h

Circulatory assist, start time

None

ECMO 14 h

None

None

None

None

None

Antiepileptic drugs

TA, MDL

MDL, PB

MDL, LEV

TA, LEV, PB

TA

TA

MDL, fPHT, TA

Abnormality on brain MRI

+

Atrophy

+

Bleeding

Infarction

+

DWI high intensity

in right hemisphere

+

T2 high intensity in right hemisphere

PCPC score 6 months after onset

4

1

5

4

2

3

1

Neurological sequelae

+

+

+

+

  1. Abbreviations: HSES hemorrhagic shock encephalopathy syndrome, AESD acute encephalopathy with biphasic seizures and late reduced diffusion, FS febrile seizure, PCPC Pediatric Cerebral Performance Category, NCSE non-convulsive status epilepticus, ECMO extracorporeal membrane oxygenation, TA thiamylal, MDL midazolam, PB phenobarbital, LEV levetiracetam, fPHT fosphenytoin, DWI diffusion-weighted imaging, MRI magnetic resonance imaging